Vanda Pharmaceuticals Debt to Equity Ratio 2006-2020 | VNDA

Current and historical debt to equity ratio values for Vanda Pharmaceuticals (VNDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Vanda Pharmaceuticals debt/equity for the three months ending June 30, 2020 was 0.00.
Vanda Pharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-06-30 $0.00B $0.43B 0.00
2020-03-31 $0.00B $0.42B 0.00
2019-12-31 $0.00B $0.41B 0.00
2019-09-30 $0.00B $0.40B 0.00
2019-06-30 $0.00B $0.30B 0.00
2019-03-31 $0.00B $0.28B 0.00
2018-12-31 $0.00B $0.28B 0.00
2018-09-30 $0.00B $0.26B 0.00
2018-06-30 $0.00B $0.25B 0.00
2018-03-31 $0.00B $0.24B 0.00
2017-12-31 $0.00B $0.13B 0.00
2017-09-30 $0.00B $0.13B 0.00
2017-06-30 $0.00B $0.13B 0.00
2017-03-31 $0.00B $0.13B 0.00
2016-12-31 $0.00B $0.13B 0.00
2016-09-30 $0.00B $0.13B 0.00
2016-06-30 $0.00B $0.12B 0.00
2016-03-31 $0.00B $0.12B 0.00
2015-12-31 $0.00B $0.13B 0.00
2015-09-30 $0.00B $0.15B 0.00
2015-06-30 $0.00B $0.15B 0.00
2015-03-31 $0.00B $0.15B 0.00
2014-12-31 $0.00B $0.16B 0.00
2014-09-30 $0.00B $0.00B 0.00
2014-06-30 $0.00B $0.00B 0.00
2014-03-31 $0.00B $0.02B 0.00
2013-12-31 $0.00B $0.04B 0.00
2013-09-30 $0.00B $0.05B 0.00
2013-06-30 $0.00B $0.01B 0.00
2013-03-31 $0.00B $0.01B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.02B 0.00
2012-06-30 $0.00B $0.02B 0.00
2012-03-31 $0.00B $0.03B 0.00
2011-12-31 $0.00B $0.03B 0.00
2011-09-30 $0.00B $0.04B 0.00
2011-06-30 $0.00B $0.04B 0.00
2011-03-31 $0.00B $0.04B 0.00
2010-12-31 $0.00B $0.04B 0.00
2010-09-30 $0.00B $0.03B 0.00
2010-06-30 $0.00B $0.03B 0.00
2010-03-31 $0.00B $0.03B 0.00
2009-12-31 $0.00B $0.02B 0.00
2009-09-30 $0.00B $0.03B 0.00
2009-06-30 $0.00B $0.03B 0.00
2009-03-31 $0.00B $0.04B 0.00
2008-12-31 $0.00B $0.05B 0.00
2008-09-30 $0.00B $0.05B 0.00
2008-06-30 $0.00B $0.06B 0.00
2008-03-31 $0.00B $0.07B 0.00
2007-12-31 $0.00B $0.08B 0.00
2007-09-30 $0.00B $0.10B 0.00
2007-06-30 $0.00B $0.12B 0.00
2007-03-31 $0.00B $0.13B 0.00
2006-12-31 $0.00B $0.03B 0.00
2006-09-30 $0.00B $0.04B 0.00
2006-06-30 $0.00B $0.05B 0.00
2006-03-31 $0.00B $0.01B 0.00
2005-12-31 $0.00B $0.03B 0.00
2005-09-30 $0.00B 0.00
2005-06-30 $0.00B 0.00
2005-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.649B $0.227B
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.093B 11.02
Amgen (AMGN) United States $140.836B 15.30
CSL (CSLLY) Australia $90.247B 0.00
Gilead Sciences (GILD) United States $85.479B 12.31
Vertex Pharmaceuticals (VRTX) United States $69.584B 38.83
Regeneron Pharmaceuticals (REGN) United States $67.209B 24.85
Illumina (ILMN) United States $51.969B 60.02
Biogen (BIIB) United States $45.680B 7.82
Seattle Genetics (SGEN) United States $27.864B 0.00
Moderna (MRNA) United States $26.765B 0.00
Genmab (GMAB) Denmark $24.812B 15.69
Genmab (GNMSF) Denmark $23.287B 5.36
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.470B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.332B 9.31
BioMarin Pharmaceutical (BMRN) United States $21.194B 153.78
Incyte (INCY) United States $20.899B 0.00
BeiGene (BGNE) Cayman Islands $19.246B 0.00
BioNTech SE (BNTX) Germany $16.065B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.938B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.037B 68.01
Horizon Therapeutics Public (HZNP) Ireland $14.950B 34.98
Exact Sciences (EXAS) United States $13.095B 0.00
Galapagos (GLPG) Belgium $12.622B 45.73
Sarepta Therapeutics (SRPT) United States $12.482B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.160B 0.00
QIAGEN (QGEN) Netherlands $11.080B 28.12
Bio-Techne Corp (TECH) United States $10.178B 70.45
Immunomedics (IMMU) United States $9.398B 0.00
Guardant Health (GH) United States $8.891B 0.00
Novavax (NVAX) United States $8.167B 0.00
Repligen (RGEN) United States $7.679B 121.88
Ascendis Pharma (ASND) Denmark $7.534B 0.00
Emergent Biosolutions (EBS) United States $7.142B 28.29
Exelixis (EXEL) United States $6.807B 24.75
Vir Biotechnology (VIR) United States $6.702B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.438B 199.43
ACADIA Pharmaceuticals (ACAD) United States $6.293B 0.00
Mirati Therapeutics (MRTX) United States $6.141B 0.00
Acceleron Pharma (XLRN) United States $5.561B 0.00
MyoKardia (MYOK) United States $5.389B 0.00
Adaptive Biotechnologies (ADPT) United States $5.364B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.204B 0.00
Zai Lab (ZLAB) China $4.723B 0.00
NeoGenomics (NEO) United States $4.447B 1342.33
MorphoSys AG (MOR) Germany $4.297B 56.31
China Biologic Products (CBPO) China $4.212B 23.42
Blueprint Medicines (BPMC) United States $4.160B 0.00
Halozyme Therapeutics (HALO) United States $4.060B 0.00
Bluebird Bio (BLUE) United States $4.033B 0.00
Global Blood Therapeutics (GBT) United States $3.799B 0.00
Amicus Therapeutics (FOLD) United States $3.799B 0.00
Arena Pharmaceuticals (ARNA) United States $3.766B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.554B 0.00
Reata Pharmaceuticals (RETA) United States $3.471B 0.00
Denali Therapeutics (DNLI) United States $3.163B 0.00
Sorrento Therapeutics (SRNE) United States $3.149B 0.00
Principia Biopharma (PRNB) United States $3.049B 0.00
Fate Therapeutics (FATE) United States $3.040B 0.00
Alkermes (ALKS) Ireland $2.992B 62.70
Twist Bioscience (TWST) United States $2.908B 0.00
Insmed (INSM) United States $2.863B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.664B 0.00
Amarin (AMRN) Ireland $2.606B 0.00
Inovio Pharmaceuticals (INO) United States $2.411B 0.00
Editas Medicine (EDIT) United States $2.199B 0.00
Seres Therapeutics (MCRB) United States $2.179B 0.00
Viela Bio (VIE) United States $2.114B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
UniQure (QURE) Netherlands $1.853B 0.00
Ligand Pharmaceuticals (LGND) United States $1.820B 61.52
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
I-Mab (IMAB) China $1.711B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.710B 0.00
Eidos Therapeutics (EIDX) United States $1.648B 0.00
Sangamo Therapeutics (SGMO) United States $1.638B 0.00
Cytokineticsorporated (CYTK) United States $1.611B 0.00
Revance Therapeutics (RVNC) United States $1.602B 0.00
Arcus Biosciences (RCUS) United States $1.577B 0.00
Zealand Pharma (ZEAL) Denmark $1.477B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.427B 0.00
Coherus BioSciences (CHRS) United States $1.391B 8.11
Mesoblast (MESO) Australia $1.379B 0.00
Zymeworks (ZYME) Canada $1.368B 0.00
Intra-Cellular Therapies (ITCI) United States $1.331B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.291B 0.00
Epizyme (EPZM) United States $1.290B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Mersana Therapeutics (MRSN) United States $1.251B 0.00
REGENXBIO (RGNX) United States $1.235B 0.00
NGM Biopharmaceuticals (NGM) United States $1.233B 0.00
Intellia Therapeutics (NTLA) United States $1.205B 0.00
Compugen (CGEN) Israel $1.201B 0.00
Alcobra (ARCT) United States $1.167B 0.00
Beam Therapeutics (BEAM) United States $1.160B 0.00
Akcea Therapeutics (AKCA) United States $1.129B 0.00
Alector (ALEC) United States $1.086B 0.00
Arvinas (ARVN) United States $1.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.023B 0.00
Adverum Biotechnologies (ADVM) United States $1.009B 0.00
Heska (HSKA) United States $1.002B 0.00
NantKwest (NK) United States $1.002B 0.00
Myriad Genetics (MYGN) United States $0.998B 0.00
Retrophin (RTRX) United States $0.949B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.935B 0.00
Athenex (ATNX) United States $0.929B 0.00
Morphic Holding (MORF) United States $0.923B 0.00
VBI Vaccines (VBIV) United States $0.869B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.834B 0.00
Castle Biosciences (CSTL) United States $0.808B 0.00
Pharming Group (PHGUF) Netherlands $0.801B 18.29
Codexis (CDXS) United States $0.793B 0.00
Cara Therapeutics (CARA) United States $0.791B 0.00
Dynavax Technologies (DVAX) United States $0.746B 0.00
Frequency Therapeutics (FREQ) United States $0.738B 0.00
Cellectis S.A (CLLS) France $0.721B 0.00
Intrexon (PGEN) United States $0.720B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.720B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Vericel (VCEL) United States $0.708B 0.00
MiMedx (MDXG) United States $0.703B 0.00
Agenus (AGEN) United States $0.695B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.648B 0.00
Protagonist Therapeutics (PTGX) United States $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.614B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.608B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Syros Pharmaceuticals (SYRS) United States $0.552B 0.00
Geron (GERN) United States $0.518B 0.00
Anika Therapeutics (ANIK) United States $0.516B 22.57
Biofrontera AG (BFRA) Germany $0.514B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
MeiraGTx Holdings (MGTX) United States $0.507B 0.00
Cel-Sci (CVM) United States $0.504B 0.00
Kala Pharmaceuticals (KALA) United States $0.501B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.500B 0.00
Innate Pharma S.A (IPHA) France $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Athersys (ATHX) United States $0.476B 0.00
AC Immune SA (ACIU) Switzerland $0.470B 0.00
Avid Bioservices (CDMO) United States $0.470B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.459B 0.00
BioDelivery Sciences (BDSI) United States $0.458B 32.43
Pfenex (PFNX) United States $0.439B 0.00
Clovis Oncology (CLVS) United States $0.431B 0.00
Scholar Rock Holding (SRRK) United States $0.410B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 9.62
IVERIC Bio (ISEE) United States $0.406B 0.00
Celldex Therapeutics (CLDX) United States $0.403B 0.00
Kamada (KMDA) Israel $0.401B 19.15
Prometic Life Sciences (LMNL) Canada $0.393B 0.00
Puma Biotechnology (PBYI) United States $0.393B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.382B 0.00
Merus (MRUS) Netherlands $0.378B 0.00
MannKind (MNKD) United States $0.376B 0.00
PDL BioPharma (PDLI) United States $0.374B 0.00
Cellular Biomedicine (CBMG) United States $0.368B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
Albireo Pharma (ALBO) United States $0.354B 0.00
WAVE Life Sciences (WVE) Singapore $0.334B 0.00
Precision BioSciences (DTIL) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.323B 0.00
IBio (IBIO) United States $0.315B 0.00
Sutro Biopharma (STRO) United States $0.314B 0.00
Trevena (TRVN) United States $0.312B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.299B 0.00
Selecta Biosciences (SELB) United States $0.280B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.280B 0.00
Arbutus Biopharma (ABUS) United States $0.278B 0.00
Starpharma Holdings (SPHRY) Australia $0.277B 0.00
Menlo Therapeutics (MNLO) United States $0.272B 0.00
Affimed (AFMD) Germany $0.262B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Spero Therapeutics (SPRO) United States $0.260B 0.00
DBV Technologies S.A (DBVT) France $0.259B 0.00
Verastem (VSTM) United States $0.258B 0.00
NextCure (NXTC) United States $0.256B 0.00
Northwest Biotherapeutics (NWBO) United States $0.245B 0.00
Dyadic (DYAI) United States $0.244B 0.00
Abeona Therapeutics (ABEO) United States $0.240B 0.00
Forte Biosciences (FBRX) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.220B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.206B 0.00
XOMA (XOMA) United States $0.205B 0.00
Aduro Biotech (ADRO) United States $0.201B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.197B 9.20
GENFIT S.A (GNFT) France $0.195B 0.00
Exicure (XCUR) United States $0.195B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Cerecor (CERC) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.184B 0.00
Aptinyx (APTX) United States $0.179B 0.00
Five Prime Therapeutics (FPRX) United States $0.174B 0.00
VTv Therapeutics (VTVT) United States $0.171B 0.00
Cyclerion Therapeutics (CYCN) United States $0.171B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Bellus Health (BLU) Canada $0.161B 0.00
TELA Bio (TELA) United States $0.159B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Gritstone Oncology (GRTS) United States $0.138B 0.00
Cardiff Oncology (CRDF) United States $0.133B 0.00
CorMedix Inc (CRMD) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.130B 0.00
Lumos Pharma (LUMO) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.126B 6.42
SESEN BIO, INC (SESN) United States $0.123B 0.00
Palatin Technologies (PTN) United States $0.123B 3.14
Oncobiologics (OTLK) United States $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.121B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Catalyst Biosciences (CBIO) United States $0.119B 0.00
Checkpoint Therapeutics (CKPT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.101B 0.00
Antibe Therapeutics (ATBPF) Canada $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.097B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
Organovo Holdings (ONVO) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.091B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
Synlogic (SYBX) United States $0.080B 0.00
AnPac Bio-Medical Science (ANPC) China $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.077B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Edesa Biotech (EDSA) Canada $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.068B 0.00
Curis (CRIS) United States $0.068B 0.00
Bionano Genomics (BNGO) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 89.50
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Novogen (KZIA) Australia $0.045B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Evogene (EVGN) Israel $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Chanticleer Holdings (SONN) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
BioPharmX (TMBR) United States $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00